CliffBio

KNOA

Patent cliffs & loss of exclusivity

21 upcoming patent cliffs

DrugIngredientTypeCliff
  1. OXYCONTINOXYCODONE HYDROCHLORIDESmall mol.Aug 2027
  2. OXYCONTINOXYCODONE HYDROCHLORIDESmall mol.Aug 2027
  3. OXYCONTINOXYCODONE HYDROCHLORIDESmall mol.Aug 2027
  4. OXYCONTINOXYCODONE HYDROCHLORIDESmall mol.Mar 2030
  5. OXYCONTINOXYCODONE HYDROCHLORIDESmall mol.Mar 2030
  6. OXYCONTINOXYCODONE HYDROCHLORIDESmall mol.Mar 2030
  7. OXYCONTINOXYCODONE HYDROCHLORIDESmall mol.Mar 2030
  8. HYSINGLA ERHYDROCODONE BITARTRATESmall mol.Dec 2031
  9. HYSINGLA ERHYDROCODONE BITARTRATESmall mol.Dec 2031
  10. HYSINGLA ERHYDROCODONE BITARTRATESmall mol.Dec 2031
  11. HYSINGLA ERHYDROCODONE BITARTRATESmall mol.Dec 2031
  12. HYSINGLA ERHYDROCODONE BITARTRATESmall mol.Dec 2031
  13. HYSINGLA ERHYDROCODONE BITARTRATESmall mol.Dec 2031
  14. HYSINGLA ERHYDROCODONE BITARTRATESmall mol.Dec 2031
  15. ADHANSIA XRMETHYLPHENIDATE HYDROCHLORIDESmall mol.Nov 2038
  16. ADHANSIA XRMETHYLPHENIDATE HYDROCHLORIDESmall mol.Nov 2038
  17. ADHANSIA XRMETHYLPHENIDATE HYDROCHLORIDESmall mol.Nov 2038
  18. ADHANSIA XRMETHYLPHENIDATE HYDROCHLORIDESmall mol.Nov 2038
  19. ADHANSIA XRMETHYLPHENIDATE HYDROCHLORIDESmall mol.Nov 2038
  20. ADHANSIA XRMETHYLPHENIDATE HYDROCHLORIDESmall mol.Nov 2038
  21. ZURNAI (AUTOINJECTOR)NALMEFENE HYDROCHLORIDESmall mol.Nov 2039
  22. BUTRANSBUPRENORPHINESmall mol.—
  23. BUTRANSBUPRENORPHINESmall mol.—
  24. BUTRANSBUPRENORPHINESmall mol.—
  25. BUTRANSBUPRENORPHINESmall mol.—
  26. BUTRANSBUPRENORPHINESmall mol.—
  27. NALMEFENE HYDROCHLORIDENALMEFENE HYDROCHLORIDESmall mol.—
  28. MS CONTINMORPHINE SULFATESmall mol.—
  29. MS CONTINMORPHINE SULFATESmall mol.—
  30. MS CONTINMORPHINE SULFATESmall mol.—
  31. MS CONTINMORPHINE SULFATESmall mol.—
  32. MS CONTINMORPHINE SULFATESmall mol.—

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

KNOA — patent cliffs & loss of exclusivity | CliffBio